DK1239862T3 - Farmaceutisk præparat indeholdende cytostatika og eletronacceptorer til behandling af kræft - Google Patents

Farmaceutisk præparat indeholdende cytostatika og eletronacceptorer til behandling af kræft

Info

Publication number
DK1239862T3
DK1239862T3 DK00979624T DK00979624T DK1239862T3 DK 1239862 T3 DK1239862 T3 DK 1239862T3 DK 00979624 T DK00979624 T DK 00979624T DK 00979624 T DK00979624 T DK 00979624T DK 1239862 T3 DK1239862 T3 DK 1239862T3
Authority
DK
Denmark
Prior art keywords
eletron
acceptors
cancer
treatment
pharmaceutical preparation
Prior art date
Application number
DK00979624T
Other languages
Danish (da)
English (en)
Inventor
Miklos Ghyczy
Joerg Hager
Armin Wendel
Original Assignee
Nattermann A & Cie
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nattermann A & Cie filed Critical Nattermann A & Cie
Application granted granted Critical
Publication of DK1239862T3 publication Critical patent/DK1239862T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/205—Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
DK00979624T 1999-12-09 2000-11-25 Farmaceutisk præparat indeholdende cytostatika og eletronacceptorer til behandling af kræft DK1239862T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19959546A DE19959546A1 (de) 1999-12-09 1999-12-09 Pharmazeutische Zubereitung zur Behandlung von Tumorerkrankungen
PCT/EP2000/011761 WO2001041747A2 (de) 1999-12-09 2000-11-25 Pharmazeutische zubeteitung enthaltend zytostatika und electronenakzeptoren zur behandlung von krebs

Publications (1)

Publication Number Publication Date
DK1239862T3 true DK1239862T3 (da) 2005-10-31

Family

ID=7932121

Family Applications (1)

Application Number Title Priority Date Filing Date
DK00979624T DK1239862T3 (da) 1999-12-09 2000-11-25 Farmaceutisk præparat indeholdende cytostatika og eletronacceptorer til behandling af kræft

Country Status (15)

Country Link
US (2) US20010021704A1 (es)
EP (1) EP1239862B3 (es)
JP (2) JP2003516348A (es)
AR (1) AR026911A1 (es)
AT (1) ATE299025T1 (es)
AU (1) AU781943B2 (es)
CA (1) CA2393487C (es)
DE (2) DE19959546A1 (es)
DK (1) DK1239862T3 (es)
ES (1) ES2243328T7 (es)
IL (2) IL149975A0 (es)
MX (1) MXPA02005045A (es)
PT (1) PT1239862E (es)
TW (1) TWI260224B (es)
WO (1) WO2001041747A2 (es)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102007009650A1 (de) * 2007-02-26 2008-08-28 Beiersdorf Ag Kosmetisches Kombinationsprodukt zur Verbesserung des äußeren Erscheinungsbildes
EP2544663B1 (en) 2010-03-12 2018-01-03 Berg LLC Intravenous formulations of coenzyme q10 (coq10) and methods of use thereof
EA201490047A1 (ru) 2011-06-17 2014-08-29 Берг Ллк Ингаляционные фармацевтические композиции
US10058542B1 (en) 2014-09-12 2018-08-28 Thioredoxin Systems Ab Composition comprising selenazol or thiazolone derivatives and silver and method of treatment therewith
IL264950B2 (en) 2016-08-23 2024-01-01 Eisai R&D Man Co Ltd Combined treatments for the treatment of malignant liver cell carcinoma
WO2018094275A1 (en) 2016-11-18 2018-05-24 Tolero Pharmaceuticals, Inc. Alvocidib prodrugs and their use as protein kinase inhibitors
IL269357B1 (en) 2017-03-16 2024-06-01 Eisai R&D Man Co Ltd A combination of Era inhibitors and a CDK4/6 inhibitor to be used in a method to treat breast cancer
JP7196160B2 (ja) 2017-09-12 2022-12-26 スミトモ ファーマ オンコロジー， インコーポレイテッド Ｍｃｌ－１阻害剤アルボシジブを用いた、ｂｃｌ－２阻害剤に対して非感受性である癌の治療レジメン
EP3890749A4 (en) 2018-12-04 2022-08-03 Sumitomo Dainippon Pharma Oncology, Inc. CDK9 INHIBITORS AND POLYMORPHS THEREOF FOR USE AS CANCER TREATMENT AGENT
US11793802B2 (en) 2019-03-20 2023-10-24 Sumitomo Pharma Oncology, Inc. Treatment of acute myeloid leukemia (AML) with venetoclax failure
CN117417397A (zh) * 2023-10-17 2024-01-19 浙江亚瑟医药有限公司 一种盐酸伊达比星晶型及其制备方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0617309B2 (ja) * 1985-11-29 1994-03-09 株式会社ビタミン研究所 アドリアマイシン包埋リポソ−ム製剤
IN164232B (es) * 1986-04-11 1989-02-04 Hoechst India
DE3836676A1 (de) * 1988-10-28 1990-05-03 Hoechst Ag Die verwendung von 4h-1-benzopyran-4-on-derivaten, neue 4h-1-benzopyran-4-on-derivate und diese enthaltende arzneimittel
DE19724796A1 (de) * 1997-06-06 1998-12-10 Max Delbrueck Centrum Mittel zur Antitumortherapie
PT1100589E (pt) * 1998-07-30 2005-05-31 Sigma Tau Ind Farmaceuti Utilizacao de propionil-l-carnitina e acetil-l-carnitina na preparacao de medicamentos com actividade anticancerigena
WO2000012071A2 (de) * 1998-08-29 2000-03-09 Miklos Ghyczy Pharmazeutisches und/oder diätetisches produkt
DE19843968A1 (de) * 1998-09-24 2000-04-13 Hans Dietl Taxane enthaltende pharmazeutische Zubereitung zur intravenösen Applikation und Verfahren zu ihrer Herstellung

Also Published As

Publication number Publication date
EP1239862B1 (de) 2005-07-06
ES2243328T7 (es) 2012-03-16
TWI260224B (en) 2006-08-21
WO2001041747A3 (de) 2002-02-07
JP2012162577A (ja) 2012-08-30
US20040235783A1 (en) 2004-11-25
CA2393487C (en) 2010-11-09
JP2003516348A (ja) 2003-05-13
WO2001041747A2 (de) 2001-06-14
DE50010681D1 (de) 2005-08-11
CA2393487A1 (en) 2001-06-14
AR026911A1 (es) 2003-03-05
ES2243328T3 (es) 2005-12-01
AU781943B2 (en) 2005-06-23
PT1239862E (pt) 2005-10-31
MXPA02005045A (es) 2003-09-25
EP1239862B3 (de) 2011-09-07
IL149975A (en) 2007-02-11
DE19959546A1 (de) 2001-06-21
IL149975A0 (en) 2002-12-01
US20010021704A1 (en) 2001-09-13
EP1239862A2 (de) 2002-09-18
ATE299025T1 (de) 2005-07-15
AU1704801A (en) 2001-06-18

Similar Documents

Publication Publication Date Title
NO20021401D0 (no) Konazolinforbindelser og farmasöytiske preparater inneholdende slike forbindelser
DK1093370T3 (da) Farmaceutisk præparat til behandling af diabetes
PT1207867E (pt) Formas de administracao farmaceuticas orais retardadas contendo tramadol
IS2468B (is) Aðferðir og milliefni til framleiðslu á efnasamböndum gegn krabbameini
DK0956858T3 (da) Farmaceutiske præparater indeholdende lactobacilli til behandling af vaginale infektioner
DK1158992T3 (da) Anvendelse af xenon til fremstilling af et farmaceutisk præparat til behandling af neurointoksikationer
EE200200357A (et) Ravimaine suurenenud kontsentratsioone andvad farmatseutilised kompositsioonid
DK0941103T3 (da) Farmaceutisk præparat til behandling af diabetes
NO20024175D0 (no) Azetidinderivater, deres fremstilling og farmasöytiske forbindelser inneholdende de samme
DK1345910T3 (da) Quinazolinderivater, lægemidler indeholdende forbindelserne, deres anvendelse og fremgangsmåde til fremstilling deraf
ATE447947T1 (de) Pharmazeutische zubereitungen zur behandlung von insulinresitenz
IS5245A (is) Lyfjablanda úr ómeprasól
DK1147083T3 (da) Arylpiperazinyl-cyclohexylindolderivater til behandling af depression
DK1202965T3 (da) Indolderivater, fremgangsmåde til fremstilling deraf, farmaceutiske præparater indeholdende disse og deres medicinske anvendelse
PL352547A1 (en) Drugs containing inhibitors of human kinase h-sgk
EE200100259A (et) Moksifloksatsiini farmatseutiline preparaat
NO20020086L (no) Smaksmaskerte farmasöytiske flytende formuleringer
HUP0700039A2 (en) Use of cannabinoid drugs for the preparation of medicines for decreasing cell proliferation
IS2223B (is) Aðferð til framleiðslu á 5-sýanóþalíði
DK0991654T3 (da) Hidtil ukendte derivater af 2-(iminomethyl)aminophenyl, deres fremstilling, deres anvendelse til medikamenter og farmaceutiske præparater indeholdende samme
EE05020B1 (et) Glburiidi ravimkoostis
NO20015516D0 (no) Preparater og anvendelser av ET743 for behandling av kreft
DK1150991T3 (da) Præparater til behandling af inflammatoriske reaktioner
NO331215B1 (no) Kit av deler og farmasoytiske formuleringer
DK1239862T3 (da) Farmaceutisk præparat indeholdende cytostatika og eletronacceptorer til behandling af kræft